BIOAVAILABILITY OF BMS-626529 IN HEALTHY SUBJECTS FROM PROTOTYPE LOW DOSE EXTENDED RELEASE FORMULATIONS (PART 1) AND PROTOTYPE EXTENDED RELEASE MULTI-PARTICULATE FORMULATIONS (PART 2) OF BMS-663068 RELATIVE TO 600 MG EXTENDED RELEASE TABLET: